138 related articles for article (PubMed ID: 31187396)
21. Liver Resection for Metastases from Gastrointestinal Stromal Tumors: Does it Improve Long-Term Survival?
Kraft A; Croitoru A; Gheorghe C; Lupescu I; Grasu M; Tomescu D; Droc G; Herlea V; Barcu A; Popescu I; Botea F
Chirurgia (Bucur); 2021 Aug; 116(4):438-450. PubMed ID: 34498563
[TBL] [Abstract][Full Text] [Related]
22. A role for adjuvant RFA in managing hepatic metastases from gastrointestinal stromal tumors (GIST) after treatment with targeted systemic therapy using kinase inhibitors.
Hakimé A; Le Cesne A; Deschamps F; Farouil G; Boudabous S; Aupérin A; Domont J; Debaere T
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):132-9. PubMed ID: 23589213
[TBL] [Abstract][Full Text] [Related]
23. A comparison between patients with gastrointestinal stromal tumours diagnosed with isolated liver metastases and liver metastases plus sarcomatosis.
de la Fuente SG; Deneve JL; Parsons CM; Zager JS; Conley AP; Gonzalez RJ
HPB (Oxford); 2013 Sep; 15(9):655-60. PubMed ID: 23458233
[TBL] [Abstract][Full Text] [Related]
24. Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis.
Sun Y; Wu M; Zhou M; Luo X; Guo Y; Bai H; Zhang Z; Tian W; Wang X; Bai Y; Zhu X; Pan H; Deng Y; Hu H; Xia J; Hao X; Han L; Wei M; Liu Y; Zeng M
BMC Cancer; 2020 Jul; 20(1):646. PubMed ID: 32660443
[TBL] [Abstract][Full Text] [Related]
25. Management of liver metastases from gastrointestinal stromal tumors: where do we stand?
Machairas N; Prodromidou A; Molmenti E; Kostakis ID; Sotiropoulos GC
J Gastrointest Oncol; 2017 Dec; 8(6):1100-1108. PubMed ID: 29299371
[TBL] [Abstract][Full Text] [Related]
26. The Efficacy of Single-Agent Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Biologically Selected Patients with Non-Small-Cell Lung Cancer: A Meta-Analysis of 19 Randomized Controlled Trials.
Li G; Gao S; Sheng Z; Li B
Chemotherapy; 2016; 61(4):179-89. PubMed ID: 26859739
[TBL] [Abstract][Full Text] [Related]
27. Retrospective study on the efficacy of bisphosphonates in tyrosine kinase inhibitor-treated patients with non-small cell lung cancer exhibiting bone metastasis.
Cui X; Li S; Gu J; Lin Z; Lai B; Huang L; Feng J; Liu B; Zhou Y
Oncol Lett; 2019 Nov; 18(5):5437-5447. PubMed ID: 31612052
[TBL] [Abstract][Full Text] [Related]
28. Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy.
Roland CL; Bednarski BK; Watson K; Torres KE; Cormier JN; Wang WL; Lazar AJ; Somaiah N; Hunt KK; Feig BW
J Surg Oncol; 2018 Apr; 117(5):879-885. PubMed ID: 29448300
[TBL] [Abstract][Full Text] [Related]
29. EGFR-TKI is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutation.
Koo DH; Kim KP; Choi CM; Lee DH; Lee JC; Lee JS; Jang SJ; Kim SW
Cancer Chemother Pharmacol; 2015 Jan; 75(1):197-206. PubMed ID: 25422153
[TBL] [Abstract][Full Text] [Related]
30. The role of surgical resection following imatinib treatment in patients with recurrent or metastatic gastrointestinal stromal tumors: results of propensity score analyses.
Park SJ; Ryu MH; Ryoo BY; Park YS; Sohn BS; Kim HJ; Kim CW; Kim KH; Yu CS; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2014 Dec; 21(13):4211-7. PubMed ID: 24980089
[TBL] [Abstract][Full Text] [Related]
31. TKIs beyond immunotherapy predict improved survival in advanced HCC.
Armstrong S; Roy T; Singh B; Kulasekaran M; Shaukat F; Geng X; Wang H; Prins P; Jha RC; Hartley ML; He AR
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2559-2574. PubMed ID: 35773429
[TBL] [Abstract][Full Text] [Related]
32. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and outcomes of gastrointestinal stromal tumor patients receiving surgery with or without TKI therapy: a retrospective real-world study.
Wang L; Ni Z; Xu W; Mei Y; Li C; Zhu Z; Liu W
World J Surg Oncol; 2023 Jan; 21(1):21. PubMed ID: 36691015
[TBL] [Abstract][Full Text] [Related]
34. Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study.
Wang W; Wang H; Lu P; Yu Z; Xu C; Zhuang W; Song Z
J Transl Med; 2019 Feb; 17(1):52. PubMed ID: 30791921
[TBL] [Abstract][Full Text] [Related]
35. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
Magnuson WJ; Lester-Coll NH; Wu AJ; Yang TJ; Lockney NA; Gerber NK; Beal K; Amini A; Patil T; Kavanagh BD; Camidge DR; Braunstein SE; Boreta LC; Balasubramanian SK; Ahluwalia MS; Rana NG; Attia A; Gettinger SN; Contessa JN; Yu JB; Chiang VL
J Clin Oncol; 2017 Apr; 35(10):1070-1077. PubMed ID: 28113019
[TBL] [Abstract][Full Text] [Related]
36. The value of hepatic resection in metastasic renal cancer in the Era of Tyrosinkinase Inhibitor Therapy.
Hau HM; Thalmann F; Lübbert C; Morgul MH; Schmelzle M; Atanasov G; Benzing C; Lange U; Ascherl R; Ganzer R; Uhlmann D; Tautenhahn HM; Wiltberger G; Bartels M
BMC Surg; 2016 Jul; 16(1):49. PubMed ID: 27444582
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST).
Ye YJ; Gao ZD; Poston GJ; Wang S
Eur J Surg Oncol; 2009 Aug; 35(8):787-92. PubMed ID: 19185444
[TBL] [Abstract][Full Text] [Related]
38. A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation?
Lv C; An C; Feng Q; Ma Y; Li S; Wang J; Zhang J; Wang X; Yan S; Fang J; Wang Y; Tan F; Yang Y
Clin Lung Cancer; 2015 Nov; 16(6):e173-81. PubMed ID: 25958850
[TBL] [Abstract][Full Text] [Related]
39. Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors.
Chen YM; Lai CH; Rau KM; Huang CH; Chang HC; Chao TY; Tseng CC; Fang WF; Chung YH; Wang YH; Su MC; Huang KT; Liu SF; Chen HC; Chang YC; Chang YP; Wang CC; Lin MC
BMC Cancer; 2016 Nov; 16(1):868. PubMed ID: 27821111
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic analysis of colorectal liver metastases treated by surgery combined with intraoperative radiofrequency ablation].
Mao R; Zhao JJ; Bi XY; Zhao H; Li ZY; Huang Z; Zhang YF; Chen X; Hu HJ; Wu XL; Hu XH; Cai JQ
Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):521-527. PubMed ID: 28655081
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
